Aleglitazar +/- atorvastatin, rosuvastatin in volunteers

Trial Profile

Aleglitazar +/- atorvastatin, rosuvastatin in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2011

At a glance

  • Drugs Aleglitazar; Atorvastatin; Rosuvastatin
  • Indications Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Diabetic nephropathies; Heart failure; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Hypolipoproteinaemia; Neurological disorders; Retinal vascular occlusion; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top